Pomdoctor Statistics
Total Valuation
Pomdoctor has a market cap or net worth of $14.37 million. The enterprise value is $78.24 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pomdoctor has 118.44 million shares outstanding. The number of shares has increased by 53.41% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 118.44M |
| Shares Change (YoY) | +53.41% |
| Shares Change (QoQ) | -26.44% |
| Owned by Insiders (%) | 21.83% |
| Owned by Institutions (%) | 0.71% |
| Float | 46.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48
| Current Ratio | 0.48 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -94.72% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 105.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $366,516 |
| Profits Per Employee | -$194,825 |
| Employee Count | 156 |
| Asset Turnover | 5.20 |
| Inventory Turnover | 39.85 |
Taxes
In the past 12 months, Pomdoctor has paid $54 in taxes.
| Income Tax | 54 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 36.81 |
| Average Volume (20 Days) | 20,637,945 |
Short Selling Information
The latest short interest is 701,443, so 0.59% of the outstanding shares have been sold short.
| Short Interest | 701,443 |
| Short Previous Month | 233,506 |
| Short % of Shares Out | 0.59% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
In the last 12 months, Pomdoctor had revenue of $57.18 million and -$30.39 million in losses. Loss per share was -$0.52.
| Revenue | 57.18M |
| Gross Profit | 7.47M |
| Operating Income | -16.66M |
| Pretax Income | -30.39M |
| Net Income | -30.39M |
| EBITDA | -16.64M |
| EBIT | -16.66M |
| Loss Per Share | -$0.52 |
Full Income StatementBalance Sheet
The company has $1.37 million in cash and $65.04 million in debt, with a net cash position of -$63.67 million or -$0.54 per share.
| Cash & Cash Equivalents | 1.37M |
| Total Debt | 65.04M |
| Net Cash | -63.67M |
| Net Cash Per Share | -$0.54 |
| Equity (Book Value) | -68.81M |
| Book Value Per Share | -0.47 |
| Working Capital | -16.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.23 million and capital expenditures -$229,863, giving a free cash flow of -$22.04 million.
| Operating Cash Flow | -21.23M |
| Capital Expenditures | -229,863 |
| Depreciation & Amortization | 21,921 |
| Net Borrowing | 2.06M |
| Free Cash Flow | -22.04M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
Gross margin is 13.07%, with operating and profit margins of -29.14% and -53.16%.
| Gross Margin | 13.07% |
| Operating Margin | -29.14% |
| Pretax Margin | -53.16% |
| Profit Margin | -53.16% |
| EBITDA Margin | -29.10% |
| EBIT Margin | -29.14% |
| FCF Margin | n/a |
